IDR 2360.0
(-2.07%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 783.59 Billion IDR | 1.79% |
2022 | 769.83 Billion IDR | 23.5% |
2021 | 623.32 Billion IDR | -2.66% |
2020 | 640.33 Billion IDR | 1.18% |
2019 | 632.85 Billion IDR | 19.95% |
2018 | 527.6 Billion IDR | 19.46% |
2017 | 441.66 Billion IDR | 8.55% |
2016 | 406.89 Billion IDR | 10.9% |
2015 | 366.9 Billion IDR | 21.05% |
2014 | 303.09 Billion IDR | 19.04% |
2013 | 254.62 Billion IDR | 24.59% |
2012 | 204.35 Billion IDR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 287.82 Billion IDR | 22.43% |
2024 Q1 | 247.4 Billion IDR | -8.46% |
2024 Q2 | 227.77 Billion IDR | -7.93% |
2023 Q2 | 233.72 Billion IDR | 8.22% |
2023 Q4 | 270.26 Billion IDR | 13.48% |
2023 Q3 | 238.16 Billion IDR | 1.9% |
2023 FY | 783.59 Billion IDR | 1.79% |
2023 Q1 | 215.98 Billion IDR | 58.52% |
2022 FY | 769.83 Billion IDR | 23.5% |
2022 Q3 | 228.26 Billion IDR | 20.36% |
2022 Q4 | 136.25 Billion IDR | -40.31% |
2022 Q2 | 189.65 Billion IDR | -12.05% |
2022 Q1 | 215.65 Billion IDR | 142.85% |
2021 Q4 | 88.79 Billion IDR | -40.41% |
2021 FY | 623.32 Billion IDR | -2.66% |
2021 Q3 | 149.01 Billion IDR | -25.98% |
2021 Q2 | 201.31 Billion IDR | 9.3% |
2021 Q1 | 184.18 Billion IDR | -2.74% |
2020 FY | 640.33 Billion IDR | 1.18% |
2020 Q4 | 189.38 Billion IDR | 34.02% |
2020 Q1 | 158.02 Billion IDR | -14.85% |
2020 Q2 | 151.61 Billion IDR | -4.06% |
2020 Q3 | 141.3 Billion IDR | -6.8% |
2019 Q4 | 185.58 Billion IDR | 18.6% |
2019 FY | 632.85 Billion IDR | 19.95% |
2019 Q3 | 156.48 Billion IDR | 6.46% |
2019 Q2 | 146.99 Billion IDR | 2.23% |
2019 Q1 | 143.78 Billion IDR | -12.41% |
2018 Q2 | 114.43 Billion IDR | -7.35% |
2018 Q1 | 123.51 Billion IDR | -5.58% |
2018 FY | 527.6 Billion IDR | 19.46% |
2018 Q4 | 164.16 Billion IDR | 30.83% |
2018 Q3 | 125.48 Billion IDR | 9.65% |
2017 Q1 | 100.5 Billion IDR | 2.88% |
2017 Q2 | 112.09 Billion IDR | 11.53% |
2017 FY | 441.66 Billion IDR | 8.55% |
2017 Q4 | 130.81 Billion IDR | 33.17% |
2017 Q3 | 98.23 Billion IDR | -12.37% |
2016 Q1 | 97.48 Billion IDR | -13.58% |
2016 FY | 406.89 Billion IDR | 10.9% |
2016 Q4 | 97.69 Billion IDR | -2.2% |
2016 Q3 | 99.89 Billion IDR | -10.65% |
2016 Q2 | 111.8 Billion IDR | 14.68% |
2015 Q3 | 89.5 Billion IDR | 3.9% |
2015 Q4 | 112.81 Billion IDR | 26.04% |
2015 FY | 366.9 Billion IDR | 21.05% |
2015 Q1 | 78.43 Billion IDR | 0.29% |
2015 Q2 | 86.14 Billion IDR | 9.83% |
2014 Q2 | 84.08 Billion IDR | 18.9% |
2014 Q4 | 78.2 Billion IDR | 11.58% |
2014 FY | 303.09 Billion IDR | 19.04% |
2014 Q3 | 70.08 Billion IDR | -16.65% |
2014 Q1 | 70.71 Billion IDR | 0.0% |
2013 FY | 254.62 Billion IDR | 24.59% |
2012 FY | 204.35 Billion IDR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
PT Bundamedik Tbk | 463.16 Billion IDR | -69.18% |
PT Metro Healthcare Indonesia Tbk | 125.19 Billion IDR | -525.902% |
PT Medikaloka Hermina Tbk | 1043.54 Billion IDR | 24.91% |
PT Murni Sadar Tbk | 224.61 Billion IDR | -248.865% |
PT Famon Awal Bros Sedaya Tbk | 293.68 Billion IDR | -166.818% |
PT Royal Prima Tbk | 75.23 Billion IDR | -941.506% |
PT Kedoya Adyaraya Tbk | 105.27 Billion IDR | -644.362% |
PT Sarana Meditama Metropolitan Tbk | 393.56 Billion IDR | -99.102% |
PT Siloam International Hospitals Tbk | 2519.46 Billion IDR | 68.898% |
PT Sejahteraraya Anugrahjaya Tbk | 583.07 Billion IDR | -34.39% |